Selection Group People
 |
|
Ed
Fritsch Visiting Scientist
Education Ph.D.,
University of Wisconsin
Interests Re-discovering the joy
of working at the bench
After training as a molecular biologist, I spent nearly 25 years
in the biotechnology industry in the discovery, development and
commercialization of human protein therapeutic products. Naturally-occurring
human proteins have proven to be extremely useful therapeutic entities
to overcome natural or induced deficiencies (such as with Factor
VIII or Erythropoietin) or as pharmacologic modifiers (such as with
Herceptin or Bone Morphogenetic Protein). My focus now is in the
development of new technology for directed protein evolution and
its application to find the next generation of protein therapeutic
drugs. |
| |
 |
 |
Elena
Getmanova Research Team Leader
I
Education B.S., St. Petersburg State University; Ph.D., Sechenov Institute of Biochemistry, Russia
Interests Drug discovery
After obtaining my B.S in genetics and molecular biology, I spent four years at the Max Planck Institute in Frankfurt, Germany, as a DAAD exchange student working on my Ph.D. in the area of glutamate receptors. After obtaining my Ph.D. in biochemistry, I worked with Professor Har Gobind Khorana at Massachusetts Institute of Technology on structure and function of G-protein coupled receptor rhodopsin. I joined the CCIB in 2004 and am interested in developing new cures and discovering novel pathways. |
| |
 |
|
Yang Jiao Research Technologist
Education M.S., San Diego State University
Interests Life sciences
I am very happy to have the opportunity of joining CCIB and do exciting research work in life sciences. I like doing hands-on work, andwill enjoy the thrill and enlightenment of experimental discoveries with my own hands. I enjoy very much the working environment of the group at CCIB, and benefit greatly learning from my senior colleagues every day. |
| |
 |
|
Alexander (Sasha) Kovtun
Research Team Leader I
Education M.S. Biochemistry, Kiev
State University, Kiev, Ukraine
Interests Research and development
of protein-based drugs
My primary research interest is in the discovery of protein drugs.
The fascinating world of direct protein evolution gives us an opportunity
to find new drugs we can rapidly apply to a wide spectrum of diseases.
I joined the group in 2004.
|
| |
 |
|
Ying Liu Research Team Leader I
Education Ph.D. Biochemistry, Jilin University, China
Interests Identification and characterization of protein-based drug candidates
My Ph. D. research focused on selection of potential therapeutics using phage-displayed peptide libraries. After that, I joined Professor Steven Hahn's laboratory at the Fred Hutchinson Cancer Research Center studying functional protein complex and kinases involved in gene regulation. At CCIB, I work with other researchers to develop novel protein-based therapeutic candidates.
|
| |
 |
|
Lin Sun
Research Project Leader
Education Ph.D in molecular biology,
UCLA
Interests Research, discovery
and development of biopharmaceuticals and biotechnology
I am interested in the discovery of proteins for therapeutic applications.
Using approaches of directed protein evolution, we are selecting and
improving molecules that interact with targets and alter their activities.
Lead molecules are further developed for preclinical and clinical
studies to evaluate their therapeutic potentials. I joinedthe CCIB
in 2004. |
| |
 |
|
Guo Tan Senior Research Lab Technologist
Education M.S., molecular genetics,
Auburn University
Interests Drug discovery and new biotechnology development
My current research work is to search for protein drugs. Before I came to the CCIB, I had been studying signal transduction pathways involved in metabolic diseases. I enjoy doing experiments and analyzing the data they produce. I also enjoy being with my husband, daughter and son. |
|
